Background illustration for clinical trials search

Sarcoma Clinical Trials

Browse 918 sarcoma clinical trials enrolling across the United States and Canada. Search by city or state to find one near you.

Filter
1
Active & Responsive

Immune Profiling of CLL/SLL Treated With First-Line Pirtobrutinib

for
Chronic Lymphocytic Leukemia (CLL),
Location: Bethesda MD
Sponsor: National Heart, Lung, and Blood Institute (NHLBI)

Sex: All

Age: 18 - 70+

Code: NCT07428707

Early_phase1, Recruiting
Active & Responsive

Genetically Engineered Cells (Anti-CD19/CD20/CD22 CAR T-cells) for the Treatment of Relapsed or Refractory Lymphoid Malignancies

for
Recurrent Acute Lymphoblastic Leukemia,
Location: Columbus OH
Sponsor: Sumithira Vasu

Sex: All

Age: 2+

Code: NCT05418088

Phase1, Recruiting
Active & Responsive

Safety and Preliminary Efficacy of MT-601 in Patients With Relapsed/Refractory Lymphoma

for
Non-Hodgkin Lymphoma, Adult, Non-Hodgkin Lymphoma, Refractory,
Location: New York NY, Madison WI, Kansas City KS, Austin TX,
Sponsor: Marker Therapeutics, Inc.

Sex: All

Age: 18 - 70+

Code: NCT05798897

Phase1, Recruiting
Active & Responsive

Allogeneic Expanded Gamma Delta T Cells With GD2 Chemoimmunotherapy in Relapsed /Refractory Neuroblastoma or Refractory/ Relapsed Osteosarcoma

for
Neuroblastoma, Refractory Neuroblastoma, Relapsed Neuroblastoma,
Location: Atlanta GA
Sponsor: Emory University

Sex: All

Age: 1+

Code: NCT05400603

Phase1, Recruiting
Active & Responsive

Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies

for
Non-small Cell Lung Cancer, Histiocytic Neoplasm, Histiocytosis,
Location: Boston MA, New Haven CT, New York NY, Fairfax VA,
Sponsor: Institut de Recherches Internationales Servier

Sex: All

Age: 18+

Code: NCT05786924

Phase1, Phase2, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image
Active & Responsive

Metronomic Gemcitabine, Mitomycin C, and Thalidomide for Advanced Solid Tumors

for
Solid Tumor Cancer
Location: Santa Monica CA
Sponsor: Sarcoma Oncology Research Center, LLC

Sex: All

Age: 18+

Code: NCT07671534

Phase2, Recruiting
Active & Responsive

KEYMAKER-U01 Substudy 01J: A Study of Pembrolizumab Plus MK-1084 in Participants With Non-Small Cell Lung Cancer (NSCLC) With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) G12C Mutations (MK-3475-01J/KEYMAKER-U01J)

for
Malignant Neoplasm
Location: Clermont FL, Fargo ND, Sioux Falls SD
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT07252739

Phase2, Recruiting

Fluorescent Intra-operative Tumor Margin Examination

for
Sarcoma
Location: Pittsburgh PA
Sponsor: Kurt Weiss

Sex: All

Age: 18 - 70+

Code: NCT04719156

Phase2, Recruiting

Palbociclib and Pembrolizumab in Sarcoma

for
Sarcoma
Location: Iowa City IA
Sponsor: John Rieth

Sex: All

Age: 12+

Code: NCT06113809

Phase1, Recruiting

Preoperative 5-Day Radiotherapy for Soft Tissue Sarcoma

for
Soft Tissue Sarcoma
Location: Charleston SC
Sponsor: Medical University of South Carolina

Sex: All

Age: 18+

Code: NCT06905132

Phase2, Recruiting

Short Course Radiation Treatment for Patients With Primary or Locally Recurrent Retroperitoneal Sarcoma Prior to Surgery

for
Retroperitoneal Sarcoma
Location: Boston MA
Sponsor: Brigham and Women's Hospital

Sex: All

Age: 18+

Code: NCT06812052

Phase1, Recruiting

Phase I Trial of TURALIO(R) (Pexidartinib, PLX3397) in Children and Young Adults With Refractory Leukemias and Refractory Solid Tumors Including Neurofibromatosis Type 1 (NF1) Associated Plexiform Neurofibromas (PN) and Tenosynovial Giant Cell Tumor ...

for
Neurofibroma, Plexiform,
Location: Bethesda MD
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 3 - 35

Code: NCT02390752

Phase1, Recruiting

BostonGene and Exigent Genomic INsight Study

for
Breast Cancer, Non-small Cell Lung Cancer, Melanoma, Sarcoma
Location: Fort Wayne IN, Rogers AR, Houston TX, Tulsa OK,
Sponsor: BostonGene

Sex: All

Age: 18+

Code: NCT06272864

Recruiting

A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML

for
Acute Myeloid Leukemia, Mixed Lineage Leukemia Gene Mutation,
Location: Boston MA, Worcester MA, New Haven CT, Stony Brook NY,
Sponsor: Kura Oncology, Inc.

Sex: All

Age: 18+

Code: NCT05735184

Phase1, Recruiting

Study Assessing the Effects of Early Psychiatric Referral on Mental Health and Quality of Life in People With Sarcoma

for
Sarcoma, Bone Sarcoma, Soft Tissue Sarcoma
Location: Commack NY, Uniondale NY, Harrison NY, New York NY,
Sponsor: Memorial Sloan Kettering Cancer Center

Sex: All

Age: 18+

Code: NCT06129903

Recruiting

Biologically-Adapted, Dose-Escalated Radiotherapy for the Treatment of Ewing Sarcoma, BEAR Trial

for
Ewing Sarcoma, Round Cell Sarcoma With EWSR1-non-ETS Fusion
Location: Rochester MN
Sponsor: Mayo Clinic

Sex: All

Age: 2+

Code: NCT07188532

Recruiting

B7-H3-Specific Chimeric Antigen Receptor Autologous T-Cell Therapy for Pediatric Patients With Solid Tumors (3CAR)

for
Pediatric Solid Tumor, Osteosarcoma, Rhabdomyosarcoma,
Location: Memphis TN
Sponsor: St. Jude Children's Research Hospital

Sex: All

Age: 0 - 21

Code: NCT04897321

Phase1, Recruiting

Repurposing Riluzole for Cancer-Related Cognitive Impairment: A Pilot Trial

for
Breast Cancer, Sarcoma, Gastric Cancer, Lung Cancer,
Location: Orange CA
Sponsor: University of California, Irvine

Sex: All

Age: 18+

Code: NCT06580002

Phase2, Recruiting

Collecting Blood and Tissue Sample Donations for Research for HIV/AIDS-Related Cancers

for
Anal Carcinoma, Hematopoietic and Lymphoid Cell Neoplasm,
Location: New York NY, Baltimore MD, Washington D.C. DC, Miami FL,
Sponsor: AIDS Malignancy Consortium

Sex: All

Age: 18+

Code: NCT05663502

Recruiting

Circulating Tumor DNA (ctDNA) for Early Treatment Response Assessment of Solid Tumors

for
Healthy Volunteer, Prostate Cancer, Head and Neck Cancer,
Location: St Louis MO
Sponsor: Washington University School of Medicine

Sex: All

Age: 18+

Code: NCT04354064

Recruiting